Use of a Physiologically Based Pharmacokinetic Model for Rats to Study the Influence of Body Fat Mass and Induction of CYP1A2 on the Pharmacokinetics of TCDD
Environmental Health Perspectives - United States
doi 10.1289/ehp.8805
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2006
Authors
Publisher
Environmental Health Perspectives